Similar experiments were run in intrahepatic, lung, cholangiocellular, pancreas, kidney, breast and colon cancer samples, also correlating poor disease prognosis to CXCR2 overexpression by cancer cells [22, 33–35]. Here, CXCR2 is linked to colonic neoplasm.